Hologic (HOLX) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4364401012
Hologic, Inc. focuses on developing, manufacturing, and providing a wide range of diagnostic products, medical imaging systems, and surgical products specifically designed for the healthcare needs of women. Operating through four main segments - Diagnostics, Breast Health, GYN Surgical, and Skeletal Health - Hologic is committed to early detection and treatment to promote women's health.
The company offers an array of cutting-edge products, including molecular diagnostic assays for detecting various infectious microorganisms, viral load assays for diseases like Hepatitis B and C, human immunodeficiency virus, as well as assays for diagnosing vaginitis. Notably, Hologic provides advanced solutions for breast health care, such as digital mammography systems, breast cancer diagnosis tools, and minimally invasive biopsy guidance systems.
In addition to its focus on breast health, Hologic also provides innovative solutions for gynecological surgical procedures, including products for fibroid and polyp removal, treating abnormal uterine bleeding, and advancements in minimally invasive orthopedic surgical procedures. The company's offerings extend to skeletal health with its dual-energy X-ray system and mini C-arm technology.
Headquartered in Marlborough, Massachusetts, Hologic operates internationally, reaching customers through various channels like direct sales, independent distributors, service forces, and sales representatives. With a history dating back to 1985, Hologic continues to be a leading force in women's health by providing comprehensive and advanced healthcare solutions. To learn more about Hologic, visit their official website here.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
HOLX Stock Overview
Market Cap in USD | 17,666m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 1990-06-21 |
HOLX Stock Ratings
Growth 5y | 4.29 |
Fundamental | 4.10 |
Dividend | - |
Rel. Performance vs Sector | -1.55 |
Analysts | 3.67/5 |
Fair Price Momentum | 71.24 USD |
Fair Price DCF | 102.31 USD |
HOLX Dividends
Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
HOLX Growth Ratios
Growth 12m | -10.65% |
Growth Correlation 12m | -28% |
Growth Correlation 3m | 52% |
CAGR 5y | 11.77% |
Sharpe Ratio 12m | -0.82 |
Alpha vs SP500 12m | -31.12 |
Beta vs SP500 5y weekly | 0.86 |
ValueRay RSI | 29.04 |
Volatility GJR Garch 1y | 23.92% |
Price / SMA 50 | -0.69% |
Price / SMA 200 | 2.3% |
Current Volume | 1576.8k |
Average Volume 20d | 1580.1k |
External Links for HOLX Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 19, 2024, the stock is trading at USD 75.10 with a total of 1,576,803 shares traded.
Over the past week, the price has changed by -3.45%, over one month by -1.64%, over three months by +2.11% and over the past year by -8.98%.
According to ValueRays Forecast Model, HOLX Hologic will be worth about 78.4 in April 2025. The stock is currently trading at 75.10. This means that the stock has a potential upside of +4.41%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 84.5 | 12.5% |
Analysts Target Price | 86.6 | 15.3% |
ValueRay Target Price | 78.4 | 4.41% |